Clinical trials
Recruiting Phase 1/2 trials in Czechia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2024 | 3 |
| 2025 | 8 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 19 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 5 |
| Novartis Pharmaceuticals | 3 |
| 4TEEN4 Pharmaceuticals GmbH | 1 |
| AstraZeneca | 1 |
| Bayer | 1 |
| Bristol-Myers Squibb | 1 |
| Curis, Inc. | 1 |
| Hoffmann-La Roche | 1 |
| Institute of Hematology and Blood Transfusion, Czech Republic | 1 |
| Ipsen | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 4 |
| Breast Neoplasms | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Esophageal Squamous Cell Carcinoma | 2 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 |
| Lymphoma, Large B-Cell, Diffuse | 2 |
| Lymphoma, Non-Hodgkin | 2 |
| Recurrence | 2 |
| Anemia, Refractory, with Excess of Blasts | 1 |
| Brain Injuries, Traumatic | 1 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.